Johnson and Johnson Merck Consumer Pharmaceuticals News
News on Johnson and Johnson Merck Consumer Pharmaceuticals continually updated from thousands of sources around the net.
1 hr ago | Environmental Leader
The Wharton School, through its Initiative for Global Environmental Leadership, partnered with Johnson & Johnson to convene healthcare professionals and share best practices for measuring the value of sustainability initiatives.
When should abortion be legal?
What Do You Know About Conspiracy Theories?
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .
Clinical trials conducted by Janssen Research & Development, LLC points to evidence that its experimental drug, siltuximab improved symptoms and shrank growths in patients with Castleman disease, a rare blood disorder that causes enlarged lymph nodes.
There isn't much of an intersection of mass tort litigation and intellectual property law, but here's a tidbit that falls squarely into that slim territory: In August of 2010, Johnson & Johnson subsidiary DePuy Orthopaedics recalled a replacement hip device-the embattled metal-on-metal ASR-for a variety of reasons.
Each The 1980s weren't just famous for bad hair and good music: Global companies stepped up, successfully dealt with disastrous crises that could have potentially destroyed them, and re-wrote the rule book of marketing.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Judy Doetterl was a sales representative for Johnson & Johnson in 2004 when federal agents placed a hidden recording device on her and sent her to tape marketing presentations at a national company sales meeting.
For dividend investors seeking top yields, the Dogs of the Dow strategy has been an easy mechanical-investing method to follow, aiming at owning the 10 top-yielding Dow stocks as of the beginning of the year, holding them throughout the year, and then repeating the process at year-end.
Applications are being accepted for $8 million in grants designed to improve the delivery of mental health and substance abuse services in Massachusetts.
A closely watched leukemia drug developed by Johnson & Johnson and Pharmacyclics Inc maintained its effectiveness in keeping the disease at bay for most patients, according to long-term follow-up data from a midstage study being presented at a major medical meeting.
Although relatively small in size, the two companies' brand lineups are robust. As such, Church & Dwight and Prestige Brands represent two of the most well-rounded investments in the space.
Sovaldi is approved to treat four different strains of hepatitis virus referred to as genotype 1-4.
This morning, Credit Suisse increased its price target on shares of Johnson & Johnson to $94 as growth from Invokana is expected to be better than originally expected.
Pfizer is one of the biopharmaceutical companies hardest hit by drugs losing patent exclusivity.
Recently, I came across Stryker on Eddy Elfenbein's excellent Crossing Wall Street blog.